Taken together, our findings support the development of CXCR3+ B cells towards lesional ASCs, which is likely mediated by brain-resident CD4+ memory T cells, as a critical pathophysiological hallmark for diagnosis of MS. This evidence concerns the gene CD4 and myeloid sarcoma.